\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ is\\ focused\\ on\\ treatment\\ of\\ the\\ lung\\ cancer\\,\\ and\\ with\\ successful\\ treatment\\ of\\ the\\ primary\\ disease\\,\\ the\\ hypertrophic\\ osteoarthropathy\\ can\\ dramatically\\ improve\\ or\\ resolve\\ completely\\.\ \(0\)\
\-\ whole\\ body\\ osseous\\ scintigraphy\\ was\\ performed\\.\\ \\ no\\ focally\\ intense\\ radiotracer\\ uptake\\ was\\ seen\\ to\\ suggest\\ osteoblastic\\ metastases\\.\\ \\ however\\,\\ irregular\\ periosteal\\ uptake\\ is\\ noted\\ in\\ the\\ femoral\\ diaphyses\\ and\\ metaphyses\\ bilaterally\\.\ \(0\)\
\-\ hypertrophic\\ pulmonary\\ osteoarthropathy\\ \\(based\\ on\\ clinical\\ presentation\\ and\\ radiographic\\ findings\\ only\\)\ \(0\)\
\-\ differential\\ considerations\\ based\\ on\\ scintigraphic\\ appearance\\ may\\ include\\:\\ \\(it\\ should\\ be\\ noted\\ that\\ in\\ this\\ case\\ the\\ scintigraphic\\ appearance\\ virtually\\ excludes\\ the\\ other\\ three\\ entities\\ noted\\ under\\ \\"common\\"\\ ddx\\ possibilities\\.\ \(0\)\
\-\ common\\:\ \(1\)\
\-\ hypertrophic\\ osteoarthropathy\\ \ \(1\)\
\-\ fibrous\\ dysplasia\\ \ \(14\)\
\-\ paget\\ disease\\ \ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ uncommon\\:\ \(0\)\
\-\ caffey\\ disease\\ \ \(0\)\
\-\ acromegaly\ \(4\)\
\-\ endosteal\\ hyperostosis\\ \\(van\\ buchem\\ disease\\)\ \(0\)\
\-\ macrodystrophia\\ lipomatosa\ \(3\)\
\-\ proteus\\ syndrome\ \(0\)\
\-\ 43\\ year\\ old\\ male\\ originally\\ presented\\ with\\ cough\\.\\ \\ chest\\ radiograph\\ showed\\ a\\ left\\ upper\\ lobe\\ consolidation\\ and\\ he\\ was\\ treated\\ with\\ antibiotics\\.\\ \\ he\\ failed\\ a\\ two\\ week\\ course\\ of\\ antibiotics\\ and\\ returned\\ for\\ follow\\ up\\ medical\\ care\\.\\ \\ a\\ chest\\ ct\\ showed\\ a\\ large\\ round\\ irregularly\\ bordered\\ mass\\ in\\ the\\ left\\ upper\\ lobe\\.\\ \\ biopsy\\ of\\ the\\ lesion\\ lead\\ to\\ the\\ diagnosis\\ of\\ adenocarcinoma\\ of\\ the\\ lung\\.\\ \\ the\\ patient\\ then\\ presented\\ to\\ our\\ service\\ for\\ osseous\\ scintigraphy\\ to\\ evaluate\\ for\\ bony\\ metastatic\\ disease\\.\ \(0\)\
\-\ this\\ finding\\ was\\ discovered\\ after\\ the\\ diagnosis\\ of\\ lung\\ carcinoma\\ was\\ made\\ and\\ a\\ bone\\ scan\\ was\\ performed\\ to\\ search\\ for\\ metasases\\.\\ \\ but\\,\\ often\\ patients\\ undergoing\\ bone\\ scan\\ for\\ other\\ reasons\\ are\\ discovered\\ to\\ have\\ \\"ho\\"\\,\\ which\\ leads\\ to\\ the\\ diagnosis\\ of\\ the\\ etiologic\\ entity\\.\ \(0\)\
\-\ in\\ addition\\ to\\ pulmonary\\ diseases\\ \\(which\\ when\\ in\\ association\\ with\\ this\\ periosteal\\ proliferation\\ often\\ results\\ in\\ \\"ho\\"\\ being\\ called\\ \\"hypertrophic\\ pulmonary\\ osteoarthropathy\\"\\)\\,\\ mediastinal\\,\\ cardiovascular\\,\\ and\\ gastrointestinal\\ diseases\\ are\\ often\\ associated\\ with\\ \\"ho\\"\\.\\ \\ the\\ \\"ho\\"\\ can\\ be\\ reversed\\ with\\ elimination\\ of\\ the\\ inciting\\ process\\.\ \(0\)\
\-\ the\\ scintigraphic\\ finding\\ is\\ often\\ evident\\ before\\ radiographic\\ changes\\ are\\ evident\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ho\\:\\ 0\\.07440722494107974\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.07247036598846332\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.057569516779784814\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.04799723093880147\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.036524087610988125\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0358217304692564\ \(0\)\
\-\ often\\:\\ 0\\.031611287519068436\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.028784758389892407\ \(0\)\
\-\ buchem\\:\\ 0\\.025552227315844923\ \(0\)\
\-\ metasases\\:\\ 0\\.025552227315844923\ \(0\)\
\-\ diseases\\:\\ 0\\.02495454444898347\ \(0\)\
\-\ discovered\\:\\ 0\\.02440781587233859\ \(0\)\
\-\ disease\\:\\ 0\\.024291087673316593\ \(0\)\
\-\ macrodystrophia\\:\\ 0\\.023543105053352328\ \(0\)\
\-\ lipomatosa\\:\\ 0\\.023543105053352328\ \(0\)\
\-\ periosteal\\:\\ 0\\.023497649212572417\ \(0\)\
\-\ evident\\:\\ 0\\.022668079104510543\ \(0\)\
\-\ elimination\\:\\ 0\\.022367843870430112\ \(0\)\
\-\ pulmonary\\:\\ 0\\.021709133132348377\ \(0\)\
\-\ proteus\\:\\ 0\\.021533982790859732\ \(0\)\
\-\ lung\\:\\ 0\\.02152312278468475\ \(0\)\
\-\ osseous\\:\\ 0\\.02103265285869996\ \(0\)\
\-\ etiologic\\:\\ 0\\.020887189888499705\ \(0\)\
\-\ diaphyses\\:\\ 0\\.020358721607937516\ \(0\)\
\-\ caffey\\:\\ 0\\.020358721607937516\ \(0\)\
\-\ excludes\\:\\ 0\\.019911908043220825\ \(0\)\
\-\ bordered\\:\\ 0\\.019911908043220825\ \(0\)\
\-\ uptake\\:\\ 0\\.01968106333156065\ \(0\)\
\-\ dramatically\\:\\ 0\\.019524860528367136\ \(0\)\
\-\ acromegaly\\:\\ 0\\.0191834604250153\ \(0\)\
\-\ based\\:\\ 0\\.018890958621837452\ \(0\)\
\-\ reversed\\:\\ 0\\.01887806762600711\ \(0\)\
\-\ radiographic\\:\\ 0\\.018802112416166573\ \(0\)\
\-\ antibiotics\\:\\ 0\\.018607051348814498\ \(0\)\
\-\ inciting\\:\\ 0\\.01834959934544492\ \(0\)\
\-\ van\\:\\ 0\\.017702806443084893\ \(0\)\
\-\ noted\\:\\ 0\\.017612358160457336\ \(0\)\
\-\ metaphyses\\:\\ 0\\.01751573826587454\ \(0\)\
\-\ possibilities\\:\\ 0\\.017340014724377628\ \(0\)\
\-\ was\\:\\ 0\\.017187435168933684\ \(0\)\
\-\ diagnosis\\:\\ 0\\.017062776789394957\ \(0\)\
\-\ entities\\:\\ 0\\.017017621579130605\ \(0\)\
\-\ focused\\:\\ 0\\.016868945363514513\ \(0\)\
\-\ focally\\:\\ 0\\.016592683972777342\ \(0\)\
\-\ showed\\:\\ 0\\.016242337785064908\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.016222152461154486\ \(0\)\
\-\ irregularly\\:\\ 0\\.016108469234623234\ \(0\)\
\-\ search\\:\\ 0\\.016108469234623234\ \(0\)\
\-\ finding\\:\\ 0\\.015965573942252065\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.015893663518235634\ \(0\)\
\-\ endosteal\\:\\ 0\\.015893663518235634\ \(0\)\
\-\ virtually\\:\\ 0\\.015693684180592297\ \(0\)\
\-\ entity\\:\\ 0\\.015165215900030112\ \(0\)\
\-\ treatment\\:\\ 0\\.015040147474790322\ \(0\)\
\-\ proliferation\\:\\ 0\\.01493320805170102\ \(0\)\
\-\ reasons\\:\\ 0\\.01471840233531342\ \(0\)\
\-\ resolve\\:\\ 0\\.014650197994994016\ \(0\)\
\-\ whole\\:\\ 0\\.014583561710284744\ \(0\)\
\-\ service\\:\\ 0\\.014331354820459732\ \(0\)\
\-\ considerations\\:\\ 0\\.014271588770596729\ \(0\)\
\-\ appearance\\:\\ 0\\.01416757435788198\ \(0\)\
\-\ originally\\:\\ 0\\.013989954717107895\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.01388454125574304\ \(0\)\
\-\ scan\\:\\ 0\\.013868240350336108\ \(0\)\
\-\ failed\\:\\ 0\\.013833238133715791\ \(0\)\
\-\ leads\\:\\ 0\\.013833238133715791\ \(0\)\
\-\ he\\:\\ 0\\.013821375895843592\ \(0\)\
\-\ performed\\:\\ 0\\.013812048296969965\ \(0\)\
\-\ paget\\:\\ 0\\.01373327820307472\ \(0\)\
\-\ presented\\:\\ 0\\.01350352252186904\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.013497493740889351\ \(0\)\
\-\ 43\\:\\ 0\\.013364712477030529\ \(0\)\
\-\ lobe\\:\\ 0\\.013329422306803096\ \(0\)\
\-\ successful\\:\\ 0\\.013196633469348356\ \(0\)\
\-\ improve\\:\\ 0\\.013196633469348356\ \(0\)\
\-\ intense\\:\\ 0\\.013116112993675674\ \(0\)\
\-\ ddx\\:\\ 0\\.013076676321050227\ \(0\)\
\-\ called\\:\\ 0\\.012999377054145413\ \(0\)\
\-\ common\\:\\ 0\\.012963867895399404\ \(0\)\
\-\ returned\\:\\ 0\\.012674977297032411\ \(0\)\
\-\ metastatic\\:\\ 0\\.012470199441252697\ \(0\)\
\-\ consolidation\\:\\ 0\\.012414257770473166\ \(0\)\
\-\ bone\\:\\ 0\\.012309766269332579\ \(0\)\
\-\ undergoing\\:\\ 0\\.012146509016470223\ \(0\)\
\-\ uncommon\\:\\ 0\\.012118230248512645\ \(0\)\
\-\ association\\:\\ 0\\.0120350125503027\ \(0\)\
\-\ upper\\:\\ 0\\.011954089886195469\ \(0\)\
\-\ completely\\:\\ 0\\.011901415138128013\ \(0\)\
\-\ lead\\:\\ 0\\.011875418993250444\ \(0\)\
\-\ chest\\:\\ 0\\.011853501449608804\ \(0\)\
\-\ our\\:\\ 0\\.011773705022782997\ \(0\)\
\-\ radiotracer\\:\\ 0\\.011557115033809268\ \(0\)\
\-\ other\\:\\ 0\\.011418194485231585\ \(0\)\
\-\ can\\:\\ 0\\.011236071608516345\ \(0\)\
\-\ under\\:\\ 0\\.01082351901154213\ \(0\)\
\-\ round\\:\\ 0\\.01070015781032823\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.01070015781032823\ \(0\)\
\-\ metastases\\:\\ 0\\.01058183318853039\ \(0\)\
\-\ for\\:\\ 0\\.0105667847629379\ \(0\)\
\-\ suggest\\:\\ 0\\.01054889475765991\ \(0\)\
\-\ mediastinal\\:\\ 0\\.01051632642934998\ \(0\)\
\-\ addition\\:\\ 0\\.010500178472684892\ \(0\)\
\-\ before\\:\\ 0\\.01048411997884253\ \(0\)\
\-\ are\\:\\ 0\\.010129338021996536\ \(0\)\
\-\ fibrous\\:\\ 0\\.010012250023933545\ \(0\)\
\-\ evaluate\\:\\ 0\\.010012250023933545\ \(0\)\
\-\ results\\:\\ 0\\.009998673649114918\ \(0\)\
\-\ bony\\:\\ 0\\.009905378905648538\ \(0\)\
\-\ to\\:\\ 0\\.009903028601576493\ \(0\)\
\-\ irregular\\:\\ 0\\.009879265659438781\ \(0\)\
\-\ made\\:\\ 0\\.00986629673075785\ \(0\)\
\-\ \\:\\:\\ 0\\.009828476660788392\ \(0\)\
\-\ dysplasia\\:\\ 0\\.009777103517231028\ \(0\)\
\-\ process\\:\\ 0\\.009536421695173086\ \(0\)\
\-\ cough\\:\\ 0\\.0094905938516176\ \(0\)\
\-\ femoral\\:\\ 0\\.009423182656938565\ \(0\)\
\-\ course\\:\\ 0\\.009346467952045337\ \(0\)\
\-\ which\\:\\ 0\\.009247214998507529\ \(0\)\
\-\ care\\:\\ 0\\.008933846803097834\ \(0\)\
\-\ then\\:\\ 0\\.008814396749049536\ \(0\)\
\-\ biopsy\\:\\ 0\\.008787516642425393\ \(0\)\
\-\ being\\:\\ 0\\.008631269497972632\ \(0\)\
\-\ presentation\\:\\ 0\\.008531596042003138\ \(0\)\
\-\ week\\:\\ 0\\.008411638893705008\ \(0\)\
\-\ \\(\\:\\ 0\\.008375208420218673\ \(0\)\
\-\ this\\:\\ 0\\.008357714898383765\ \(0\)\
\-\ three\\:\\ 0\\.008349635444483798\ \(0\)\
\-\ cancer\\:\\ 0\\.008142508012651494\ \(0\)\
\-\ bilaterally\\:\\ 0\\.008135377502967835\ \(0\)\
\-\ body\\:\\ 0\\.008044242645475607\ \(0\)\
\-\ should\\:\\ 0\\.007896256643155943\ \(0\)\
\-\ radiograph\\:\\ 0\\.007889706243250326\ \(0\)\
\-\ follow\\:\\ 0\\.007870143396946186\ \(0\)\
\-\ differential\\:\\ 0\\.007863651679283854\ \(0\)\
\-\ be\\:\\ 0\\.007639169410689445\ \(0\)\
\-\ clinical\\:\\ 0\\.007621187826278273\ \(0\)\
\-\ medical\\:\\ 0\\.007621187826278273\ \(0\)\
\-\ only\\:\\ 0\\.007447570024594017\ \(0\)\
\-\ treated\\:\\ 0\\.007414060394445969\ \(0\)\
\-\ primary\\:\\ 0\\.007337345689552743\ \(0\)\
\-\ in\\:\\ 0\\.007328647480700085\ \(0\)\
\-\ changes\\:\\ 0\\.007098689786188581\ \(0\)\
\-\ two\\:\\ 0\\.007093713732220307\ \(0\)\
\-\ when\\:\\ 0\\.007093713732220307\ \(0\)\
\-\ syndrome\\:\\ 0\\.00708378717894099\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007020080202944541\ \(0\)\
\-\ include\\:\\ 0\\.006948270979797932\ \(0\)\
\-\ however\\:\\ 0\\.006896719001730639\ \(0\)\
\-\ the\\:\\ 0\\.006812283594091706\ \(0\)\
\-\ up\\:\\ 0\\.0066604265247948505\ \(0\)\
\-\ patients\\:\\ 0\\.006410361157582684\ \(0\)\
\-\ on\\:\\ 0\\.006294704455351549\ \(0\)\
\-\ \\,\\:\\ 0\\.00627733485257478\ \(0\)\
\-\ \\)\\:\\ 0\\.006204675583593958\ \(0\)\
\-\ associated\\:\\ 0\\.005844819020022324\ \(0\)\
\-\ a\\:\\ 0\\.005747823214762337\ \(0\)\
\-\ it\\:\\ 0\\.005567676476907295\ \(0\)\
\-\ left\\:\\ 0\\.005542639242161825\ \(0\)\
\-\ may\\:\\ 0\\.00543283585187862\ \(0\)\
\-\ case\\:\\ 0\\.005418853428600785\ \(0\)\
\-\ large\\:\\ 0\\.005416065019800231\ \(0\)\
\-\ have\\:\\ 0\\.005363588632942295\ \(0\)\
\-\ but\\:\\ 0\\.0052826182638653265\ \(0\)\
\-\ findings\\:\\ 0\\.0052719911182317674\ \(0\)\
\-\ after\\:\\ 0\\.005124641166983196\ \(0\)\
\-\ lesion\\:\\ 0\\.005045087611595521\ \(0\)\
\-\ seen\\:\\ 0\\.004894572797297653\ \(0\)\
\-\ is\\:\\ 0\\.0048894850294323965\ \(0\)\
\-\ male\\:\\ 0\\.0044788566315578935\ \(0\)\
\-\ that\\:\\ 0\\.00427820501031543\ \(0\)\
\-\ and\\:\\ 0\\.0036523566380450116\ \(0\)\
\-\ ct\\:\\ 0\\.003464648270701574\ \(0\)\
\-\ mass\\:\\ 0\\.0034448145128914915\ \(0\)\
\-\ of\\:\\ 0\\.0030392295860344806\ \(0\)\
\-\ or\\:\\ 0\\.002902964489749877\ \(0\)\
\-\ year\\:\\ 0\\.0027713196210809123\ \(0\)\
\-\ old\\:\\ 0\\.0025360423097456654\ \(0\)\
\-\ no\\:\\ 0\\.0024940410165327593\ \(0\)\
\-\ patient\\:\\ 0\\.002482875162076487\ \(0\)\
\-\ with\\:\\ 0\\.0020348552363459085\ \(0\)\
\-\ \\.\\:\\ 0\\.001646355297268233\ \(0\)\
